- freely available
Int. J. Environ. Res. Public Health 2010, 7(10), 3831-3841; doi:10.3390/ijerph7103831
Abstract: We have assessed the prevalence of Escherichia coli O157 in diarrhoeal patients and surface waters from some selected sources in Zaria (Nigeria), evaluating the antibiotic susceptibility and plasmid profiles of 184 E. coli isolates, obtained from 228 water samples and 112 diarrhoeal stool specimens (collected from children aged <15 years), using standard methods. The detection rate of E. coli O157 in surface waters was 2.2% and its prevalence in children with diarrhoea was 5.4%. The most active antibiotics were gentamicin, chloramphenicol and fluoroquinolones. Seventy-nine (42.9%) of 184 E. coli isolates were resistant to four or more antibiotics. Multidrug resistance (MDR) was higher amongst aquatic isolates than the clinical isolates. Out of 35 MDR isolates (20 of which were O157 strains), 22 (62.9%) harboured plasmids all of which were no less than 2.1 kb in size. Amongst the 20 E. coli O157 strains, only seven (35.0%) contained multiple plasmids. An aquatic O157 isolate containing two plasmids was resistant to seven drugs, including ampicillin, cefuroxime, ciprofloxacin, cotrimoxazole, nalidixic acid, nitrofurantoin and tetracycline. Loss of plasmid correlated with loss of resistance to antibiotics in cured (mutant) strains selected in tetracycline (50 μg/mL)-nutrient agar plates. Our findings revealed that plasmids were prevalent in both the aquatic and clinical isolates, and suggest that the observed MDR is plasmid-mediated. The occurrence of plasmid-mediated multidrug resistant E. coli O157 in surface waters used as sources for drinking, recreation and fresh produce irrigation heightens public health concern.
Antimicrobial resistance in Enterobacteriaceae poses a critical public health threat, especially in the developing countries [1,2]. Much of the problem has been shown to be due to the presence of transferable plasmids encoding multidrug resistance and their dissemination among different enterobacterial species [3–6].
Escherichia coli O157 is an important food-borne and water-borne pathogen with a worldwide distribution . The first reported outbreak of E. coli O157 infection in the developing world occurred in 1992 in Southern Africa . Outbreaks have also occurred in Central African Republic in 1996 and Cameroon, in 1997 . Such outbreaks have been linked to contaminated bovine food products, contaminated drinking water and flood irrigation with water contaminated by animal faeces or surface runoff [8,10], and cattle faeces have been implicated as the major source of contamination .
Although not in outbreak proportions, E. coli O157:H7 illnesses have also been reported in Southern Nigeria [12–14]. The absence of reports on the prevalence of E. coli O157 and its associated infections in Northern Nigeria (where cattle is widely reared and surface waters serve as important sources of water for drinking, herd watering and fresh produce irrigation) and a heightened concern over the spread of antimicrobial resistant pathogens made this research imperative. We isolated E. coli from surface waters and patients (children aged <15 years) with diarrhoea in parts of Zaria, Nigeria, determined the prevalence of E. coli O157 strains, evaluated the antimicrobial susceptibility of all aquatic and clinical E. coli isolates, and screened multidrug resistant strains for plasmids.
2. Experimental Section
2.1. Isolation and Identification of E. coli and E. coli O157 Strains
The study area, as well as the collection of samples, has been described fully in our previous reports [15,16]. The stool samples were collected from diarrhoeal patients (children aged <15 years) from two hospitals, the Ahmadu Bello University (ABU) Sick Bay and Jama’a Clinic, Samaru, Zaria. E. coli was isolated from water samples using the Tryptic Soy Broth (TSB) enrichment and high temperature incubation method described by LeJeune et al. . Briefly, 20 mL of each water sample was combined with equal volume of double strength TSB (Difco; Detroit, MI, USA) in a cotton-plugged 150 mL conical flask and incubated at 44.5 °C for 24 h. The resulting suspension (50 μL) was then spread plated into EMB agar. At least three discrete colonies from each water sample were randomly selected from each EMB agar plate and screened for on Sorbitol MacConkey (SMAC) agar plates (Oxoid; Basingstoke, UK). Stool specimens were cultured for E. coli isolation on EMB agar and incubated at 44.5 °C as described by Okeke et al.  and screened on SMAC. After incubation at 37 °C for 24 h all non-sorbitol (colourless) colonies were subjected to confirmation as E. coli isolates by Gram-staining and standard biochemical tests and recorded as presumptive E. coli O157. Confirmation of E. coli O157 was done by testing for agglutination with E. coli O157 antisera (Oxoid). EHEC strain EDL 933 was used as positive control.
2.2. Antimicrobial Susceptibility Testing
All E. coli isolates were tested for antimicrobial resistance using the method of Bauer et al.  on standard antibiotic discs (PS003G-VE, Polytes Laboratories, Enugu, Nigeria) using the following antibiotics: ampicillin (25 μg), cefuroxime (20 μg), chloramphenicol (10 μg), ciprofloxacin (5 μg), cotrimoxazole (50 μg), gentamicin (10 μg), nalidixic acid (30 μg), nitrofurantoin (100 μg), norfloxacin (10 μg) and tetracycline (50 μg). E. coli ATCC 25922 was used as control organism, and the results were interpreted using the Clinical and Laboratory Standards Institute (CLSI) criteria .
2.3. Plasmid Extraction, Screening and Curing
Extraction of plasmid DNA was done using the alkaline lysis method of Birnboim and Doly . A 0.8% (w/v) agarose gel was used. Crude DNA extract solutions were subjected to electrophoresis using a horizontal apparatus—the Minnie submarine agarose gel unit (HE33; Hoefer, San Francisco, CA, USA) and a constant voltage (60V) power source (P500B; Sigma, St. Louis, MO, USA) for 2–3 h as described Meyers et al. . Gels were observed using a 302 nm UV trans-illuminator (Vilber Lourmat) and photographed with a Polaroid camera. The sizes of the plasmids were estimated as described elsewhere [22,23]. The sodium dodecyl sulphate (SDS) treatment method of Tomoeda et al.  was used for plasmid curing. Tetracycline-resistant, plasmid-containing E. coli isolates were chosen and subjected to curing and antibiotic susceptibility testing. After the curing experiments, the tetracycline-susceptible, lactose-fermenting and indole-positive colonies found to have lost their plasmid(s) were considered cured (mutant) E. coli strains, transferred onto nutrient agar slants, incubated at 37 °C for 24 h, and subjected to antibiotic susceptibility testing as already described, using the same set of antibiotics.
3. Results and Discussion
3.1. Prevalence of E. coli O157and Antibiotic Susceptibility of Isolates
A total of 184 E. coli isolates were obtained from 228 water samples and 112 diarrhoeal stool specimens. Twenty-one (11.4%) of these 184 isolates were found to be non-sorbitol-fermenting, out of which 20 (95.2%) were confirmed to be E. coli O157 by slide agglutination. Table 1 shows the prevalence of Escherichia coli O157 in surface waters and among diarrhoeal patients. Only five of the 228 water samples were positive for E. coli O157, corresponding to an isolation rate of 2.2 %. Only six of the 112 stool specimens gave positive cultures of E. coli O157, and hence a prevalence of 5.4%.
Table 2 shows the antimicrobial susceptibility patterns of 184 E. coli, isolated from clinical and water samples, using 10 antibiotics. Gentamicin, norfloxacin and chloramphenicol were the most active. While all of the clinical isolates were sensitive to both gentamicin and norfloxacin, and only 6.8% was resistant to chloramphenicol, only 2.1%, 4.9% and 5.4% of the aquatic isolates were, resistant to the three antibiotics, respectively. Also, of the 184 isolates, 154 (83.7%) and 123 (66.8%) were resistant to ampicillin and tetracycline, respectively, implying that ampicillin and tetracycline were the least active.
Table 3 reveals the multidrug resistance (MDR) patterns of the 184 E. coli isolates. MDR was higher amongst aquatic isolates than the clinical isolates. While 58 (60.4 %) of the aquatic strains showed resistance to ampicillin, tetracycline and nitrofurantoin, only 22 (25 %) of the clinical isolates gave similar results. Overall, higher numbers of resistant isolates were identified among the aquatic isolates. The highest levels of MDR observed were in two aquatic isolates: one was resistant to eight antibiotics and another to nine of the 10 antibiotics tested, including ampicillin, cefuroxime, chloramphenicol, ciprofloxacin, cotrimoxazole, gentamicin, nalidixic acid, norfloxacin and tetracycline.
Table 4 shows that amongst the 20 E. coli O157 isolates (14 aquatic and six clinical strains), the most active antibiotics were the fluoroquinolones and chloramphenicol. While none (0.0 %) was resistant to norfloxacin, three (15 %) showed intermediate susceptibility and 17 (85 %) were sensitive. For ciprofloxacin, while 18 (90%) were sensitive, only 2 (10%) were sensitive. Seventeen (85 %) were sensitive to chloramphenicol. Further, 16 (80 %) of the E. coli O157 isolates were sensitive to each of cotrimoxazole and gentamicin. All (100 %) of the six clinical O157 isolates were sensitive to ciprofloxacin and chloramphenicol, while five (83.3 %) and three (50 %) were resistant to tetracycline and ampicillin respectively. Amongst the 14 aquatic isolates, while 10 (71.4%) were resistant to ampicillin and tetracycline, nine (64.3%) were resistant to nitrofurantoin and 13 (93%) to chloramphenicol.
3.2. Plasmid Studies
Thirty-five multidrug-resistant E. coli isolates were screened for plasmids. This consisted of 23 aquatic and 12 clinical isolates, grouped further into 20 E. coli O157 strains and 15 non-O157 strains. Table 5 shows that 22 (62.9%), of the 35, haboured plasmids (>2.1 Kb). The table further reveals that out of the 22 plasmid-containing isolates, only seven (JC17, JC15, LR 11, BS12, AS04, FD08 and FD07), marked with asterisks (*) are E. coli O157 strains. All (100%) of the 15 non-O157 isolates contained plasmids. The resistance level observed in this 22 ranged from two-drug resistance (Isolate JC17) to nine-drug resistance (Isolate AS03).
All (100%) of the 22 plasmid-containing isolates were resistant to tetracycline, while only 10 (45.5%) were resistant to ciprofloxacin. In all, eight isolates contained two or more plasmids, giving a prevalence of 22.9%. Each of the isolates bearing multiple plasmids was resistant to at least four antibiotics. Interestingly, Isolate AS03 which showed resistance to nine different antibiotics contained only one plasmid.
Amongst the 20 E. coli O157 isolates, the DNA fingerprints revealed that only seven (35%) contained plasmids, out of which three (15%) contained more than one plasmid. One of the aquatic isolates (FD07) containing two plasmids was resistant to seven drugs including ampicillin, cefuroxime, ciprofloxacin, cotrimoxazole, nalidixic acid, nitrofurantoin and tetracycline. No clinical E. coli O157 isolate contained multiple plasmids.
Plasmid curing experiments were carried out to determine if the drug resistance observed in this study was plasmid-mediated. No plasmid bands were observed after the electrophoretic separation of crude DNA extracts from seven tetracycline-susceptible mutants. Loss of plasmids correlated with loss of resistance to antibiotics in cured strains selected on tetracycline (50 μg/mL)-nutrient agar plates. Loss of resistance to multiple antibiotics was also observed. Six (86%) of the tetracycline-susceptible mutant showed sensitivity to tetracycline and ampicillin.
The detection of E. coli O157 at relatively high frequencies in these waters (stream, 1.7%; dam, 2.7%; river, 2.1%) and its occurrence heighten public health concern about these surface waters that are sources of raw water treated for drinking, recreation, irrigation and herd watering . Kubanni River, used by local farmers for the irrigation of commercial crops (tomatoes, lettuce, cabbage, onions, spinach, sugarcane etc), has been reported as unfit for fresh produce irrigation . The 5.4% prevalence of E. coli O157 in children with diarrhoea suggests that the epidemiological situation in Nigeria had remained the same since 1994 .
Comparison of antibiotic susceptibility in clinical and water isolates showed that higher levels of resistance existed in the aquatic isolates. This agrees with the findings of Idika , who studied Vibrio cholerae isolates during an outbreak of cholera in Lagos in 1997 and reported that the isolates from water were resistant to tetracycline and gentamicin whereas clinical isolates were susceptible. Our findings which are not enough to suggest any epidemiological link between the aquatic and clinical strains concur with that of Okoh and Igbinosa . They studied antibiotic susceptibility patterns of the Vibrio isolates as well as the distribution of antibiotic resistance genes in the isolates and found that previous use of antibiotics in earlier outbreaks may be, in part, responsible for the extensive increase in antibiotics resistance. It is unknown whether the isolates responsible for earlier and recent epidemics are of the same clonal origin. The association between the development of resistance to ampicillin and tetracycline with large-scale use of antibiotics for treatment and prophylaxis of diarrhoea is well recognized Idika . Ash et al.  also reported high levels of resistance in gram-negative bacteria in rivers in the United States.
All (100%) of the 22 plasmid-containing isolates were resistant to tetracycline. This is worrisome considering that tetracycline is a first line drug in Nigeria, and as in most developing countries, people with gastrointestinal infections readily purchase it across the counter for self-medication.
From the results, it appears that plasmids are ubiquitous in bacterial population in the waters. Different plasmids (2–3) often coexisted in the same host cell. This agrees with the finding of Fujita et al.  who isolated 45 antibiotic resistant bacteria from wastewater samples and detected 31 plasmids in 14 of 45 antibiotic resistant strains with 10 carrying multiple (2–4) plasmids. The demonstration of high-molecular-weight plasmids in the isolates, and the finding that the expressed multi-drug resistance (MDR) was plasmid-mediated is significant. McPherson and Gealt  showed that several enteric bacterial strains isolated from wastewater samples and possessing both antibiotic resistance and high molecular-weight plasmids could transfer their resistance to other recipient bacteria. The transmissibility of resistance (R)-genes and plasmids poses public health risk, considering the vast potential of hosts presented by microbial populations in the gut and water environment. This risk could be heightened if R-genes are disseminated across geographic borders by travellers or by a river continuum, like Kubanni that traverses different communities within the study area.
Mutant cells obtained by SDS treatment of tetracycline-resistant isolates were susceptible to tetracycline suggesting that a part or all of their resistance genes must have been deleted by SDS action. Loss of plasmids correlated with loss of resistance to ampicillin, chloramphenicol, ciprofloxacin, norfloxacin and tetracycline in 6 (86%) of the mutants. It therefore appears that the observed multi-drug resistance to these antibiotics was plasmid-mediated. This agrees with previous findings.
Ash et al.  had in a study of the antibiotic resistance of gram-negative bacteria in rivers in the United States demonstrated that resistance to ampicillin and other drugs (including ciprofloxacin, tetracycline, chloramphenicol, kanamycin and streptomycin) was plasmid-mediated. Interestingly, two mutants now resistant to cotrimoxazole originated from wild-type E. coli O157 isolates that were sensitive to the same drug. This could be attributed to possible mutation affecting chromosomal genes in the course of the curing experiment .
Pathogenic Escherichia coli isolated from these surface water and clinical sources were found to be resistant to tetracycline, cotrimoxazole, ampicillin and other commonly used antibiotics. Higher levels of resistance were observed in aquatic isolates. Multidrug resistance and plasmid were observed in both aquatic and clinical isolates. Loss of plasmids due to treatment with sodium dodecyl-sulphate correlated with loss of resistance to antibiotics, suggesting that the observed multidrug resistance was plasmid-mediated. The occurrence of plasmid-mediated multidrug resistance in bacteria in these surface waters heightens the public health concern. The study showed a need for a continuous pollution monitoring programme of the surface waters in Nigeria.
- World Healths Organization (WHO). The world health report 1996—Fighting disease, fostering development. World Health Forum 1997, 18, 1–8.
- Karlowsky, JA; Jones, ME; Thornsberry, C; Friedland, IR. Trends in antimicrobial susceptibilities among Enterobacteriacae isolated from hospitalized patients in the United States from 1998–2001. Antimicrob. Agents Chemother 2003, 47, 1672–1680.
- McPherson, P; Gealt, M. Isolation of indigenous wastewater bacterial strains capable of mobilizing plasmid pBR325. Appl. Environ. Microbiol 1986, 51, 904–909.
- Leff, LG. Stream bacterial ecology: A neglected field? Amer. Soc. Microbiol. (ASM) News 1994, 60, 135–138.
- Blake, DP; Humphry, RW; Scott, KP; Hillman, K; Fenlon, DR; Low, JC. Influence of tetracycline exposure on tetracycline resistance and the carriage of tetracycline resistance genes within commensal Escherichia coli populations. J. Appl. Microbiol 2003, 94, 1087–1097.
- Carattoli, A. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother 2009, 53, 2227–2238.
- Chalmers, RM; Aird, A; Bolton, FJ. Waterborne Escherichia coli O157. J. Appl. Microbiol 2000, 88, 124S–132S.
- Effler, P; Isaacson, M; Arntzen, L; Heenan, R; Canter, P; Barrett, T; Lee, L; Mamba, C; Levine, W; Zaidi, A; Griffin, PM. Factors contributing to the emergence of Escherichia coli O157:H7 in Africa. Emerg. Infect. Dis 2001, 7, 812–819.
- Cunin, P; Tedjouka, E; Germani, Y; Ncharre, C; Bercoin, R; Morvan, J. An epidemic of bloody diarrhoea: E. coli O157 emerging in Cameroon? Emer. Infect. Dis 1999, 5, 285–290.
- Solomon, EB; Yaron, S; Mathews, KR. Transmission of Escherichia coli O157:H7 from contaminated manure and irrigation water to lettuce plant tissue and its subsequent internalization. Appl. Environ. Microbiol 2002, 68, 397–400.
- Renter, DG; Sargeant, JM; Oberst, RD; Samadpour, M. Diversity, frequency, and persistence of Escherichia coli O157 strains from range cattle environment. Appl. Environ. Microbiol 2003, 69, 542–547.
- Ogunsanya, TI; Rotimi, VO; Adenuga, A. Study of the aetiological agents of childhood diarrhoea in Lagos, Nigeria. J. Med. Microbiol 1994, 40, 10–14.
- Akinyemi, KO; Oyefolu, AO; Opere, B; Otunba-Payne, VA; Owuru, AO. Escherichia coli in patients with acute gastroenteritis in Lagos, Nigeria. East Afri. Med. J 1998, 75, 512–515.
- Olorunshola, ID; Smith, SI; Coker, AO. Prevalence of EHEC O157:H7 in patients with diarrhoea in Lagos, Nigeria. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS) 2000, 108, 761–763.
- Agbogu, VN; Umoh, VJ; Okuofu, CA; Smith, SI; Ameh, JB. Study of the bacteriological and physicochemical indicators of pollution of surface waters in Zaria, Nigeria. Afri. J. Biotechnol 2006, 5, 732–737.
- Chigor, VN; Umoh, VJ; Smith, SI. Occurrence of Escherichia coli O157 in a river used for fresh produce irrigation in Nigeria. Afri. J. Biotechnol 2010, 9, 178–182.
- LeJeune, JT; Besser, TE; Rice, DH; Itancock, DD. Methods for the isolation of waterborne Escherichia coli O157:H7. Lett. Appl. Microbiol 2001, 32, 316–320.
- Okeke, IN; Edelman, R. Dissemination of antibiotic resistant bacteria across geographic borders. Clin. Infect. Dis 2001, 33, 364–369.
- Bauer, AW; Kirby, WM; Sherris, JC; Turck, M. Antibiotic susceptibility testing by a standardized single disc method. Am. J. Clin. Pathol 1966, 45, 493–496.
- Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement, M100-S15; Clinical and Laboratory Standards Institute Wayne (CLSI): Chicago, IL, USA, 2005; Volume 25.
- Birnboim, HC; Doly, J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acid Res 1979, 7, 1513–1523.
- Meyers, JA; Sanchez, D; Elwell, LP; Falkow, S. Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid. J. Bacteriol 1976, 127, 1529–1537.
- Hansen, JB; Olsen, RH. Isolation of large bacterial plasmids and characterization of the P2 incompatibility group plasmids pMG1 and pMG5. J. Bacteriol 1978, 135, 227–238.
- Tomoeda, M; Inuzuka, M; Kudo, N; Kakamura, S. Effective elimination of drug resistance and sex factors in Escherichia coli by sodium dodecyl sulphate. J. Bacteriol 1968, 95, 1078–1089.
- Idika, N. The Efficacy of Water Purification Methods in the Control of Diarrhoeal Pathogens in Rural Communities of Lagos State. Ph.D. Thesis; University of Lagos: Lagos, Nigeria, 1999, 53.
- Okoh, AI; Igbinosa, EO. Antibiotic susceptibility profiles of some Vibrio strains isolated from wastewater final effluents in a rural community of the Eastern Cape Province of South Africa. BMC Microbiol 2010, 10, 143.
- Ash, RJ; Mauck, B; Morgan, M. Antibiotic resistance of gram-negative bacteria in rivers, United States. Emerg. Infect. Dis 2002, 8, 713–716.
- Fujita, M; Ike, M; Suzuki, H. Screening of plasmids from wastewater bacteria. Water Res 1993, 27, 949–953.
- Wang, H; Dzink-Fox, JL; Chen, M; Levy, SB. Genetic characterization of highly flouroquinolone-resistant clinical Escherichia coli strains from China: Role of acrR mutations. Antimicrob. Agents Chemother 2001, 45, 1515–1521.
|Table 1. Prevalence of Escherichia coli O157 in Surface waters and among Diarrhoeal Patients in Zaria, Nigeria.|
|Sample||Source||Number (%) of Collected Samples||Number (%) positive for E. coli O157|
|Water||Samaru Stream||58 (25.4)||1 (1.7)|
|Kubanni River||96 (42.1)||2 (2.1)|
|ABU Dam||74 (32.5)||2 (2.7)|
|Total||228 (100.0)||5 (2.2)|
|Diarrhoeal Stool||ABU Sick Bay||35 (31.3)||1 (2.9)|
|Jama’a Clinic||77 (68.7)||5 (6.5)|
|Total||112 (100.0)||6 (5.4)|
|Table 2. Antimicrobial Susceptibility Pattern of E .coli Isolated from Clinical and Water Samples.|
|S/N||Antimicrobial Agent||Symbol||Disc Content (μg)||Susceptibility|
|Clinical Isolates (n = 88)||Aquatic Isolates (n = 96)||Resistant Isolates Combined (n= 184) No. (%)|
|R No. (%)||I No. (%)||S No. (%)||R No. (%)||I No. (%)||S No. (%)|
|1||Ampicillin||Amp||25||71 (80.7)||14 (15.9)||3 (3.4)||83 (86.5)||5 (5.2)||8 (8.3)||154 (83.7)|
|2||Cefuroxime||Cef||20||28 (31.8)||9 (10.2)||51 (58.0)||71 (74.0)||11 (11.4)||14 (14.6)||99 (53.8)|
|3||Chloramphenicol||Chl||10||6 (6.8)||0 (0.0)||82 (93.2)||4 (4.2)||1 (1.0)||91 (94.8)||10 (5.4)|
|4||Ciprofloxacin||Cip||5||17 (19.3)||3 (3.4)||68 (77.3)||11 (11.5)||2 (2.1)||83 (86.4)||28 (15.2)|
|5||Cotrimoxazole||Cot||50||9 (10.2)||2 (2.3)||77 87.5||14 (14.6)||2 (2.1)||80 (83.3)||23 (12.5)|
|6||Gentamicin||Gen||10||0.(0.0)||0 (0.0)||88 (100)||2 (2.1)||7 (7.3)||87 (90.6)||2 (1.1)|
|7||Nalidixic Acid||Nal||30||48 (54.6)||9 (10.2)||31 (35.2)||68 (70.8)||9 (9.4)||19 (19.8)||116 (63.0)|
|8||Nitrofurantoin||Nit||100||45 (51.2)||6 (6.8)||37 (42.1)||76 (79.1)||4 (4.2)||16 (16.7)||121 (65.8)|
|9||Norfloxacin||Nor||10||0 (0.0)||6 (6.8)||82 (93.2)||9 (9.4)||5 (5.2)||82 (85.4)||9 (4.9)|
|10||Tetracycline||Tet||50||54 (61.4)||5 (5.6)||29 (33.0)||69 (71.9)||7 (7.3)||20 (20.8)||123 (66.8)|
Legend: R, resistant; I, intermediate; S, sensitive.
|Table 3. Resistance Patterns of Aquatic and Clinical in E. coli Isolates.|
|Number of Antibiotics||Combination of Antibiotics*||Aquatic Isolates (n = 96)||Clinical Isolates (n = 88)||Total||E. coli O157|
|(n = 184)||Isolates (n = 20)|
|3||Amp, Cot, Nit||9(9.4)||3(3.4)||12(6.5)||1(5.0)|
|3||Amp, Tet, Cot||9(9.4)||4(4.5)||13(7.1)||1(5.0)|
|3||Amp, Tet, Nit||58(60.4)||22(25.0)||80(43.5)||9(45.0)|
|4||Amp, Tet, Nal, Nit||50(52.1)||21(23.4)||71(38.6)||9(45.0)|
|5||Amp, Tet, Cip, Nal, Nit||8(8.3)||5(5.7)||13(7.1)||1(5.0)|
|6||Amp, Tet, Cip, Cot, Nal, Nit||6(6.3)||3(3.4)||9(4.9)||1(5.0)|
|7||Amp, Tet, Cip, Cef, Cot, Nal, Nit||2(2.1)||1(1.1)||3(1.6)||1(5.0)|
|8||Amp, Tet, Cip,Cef, Cot,Chl, Nal, Nit||1(1.0)||0(0.0)||1(0.5)||0(0.0)|
|9||Amp, Tet, Cip,Cef, Cot,Chl, Gen, Nal, Nor||1(1.0)||0(0.0)||1(0.5)||0(0.0)|
Symbols: Amp, ampicillin; Cef, cefuroxime; Cot, cotrimoxazole; Tet, tetracycline; Chl, chloramphenicol; Nit, nitrofurantoin; Nal, nalidixic acid; Cip, ciprofloxacin; Gen, gentamicin; Nor, norfloxacin.
|Table 4. Antimicrobial susceptibility pattern of E. coli O157 strains isolated from clinical and water samples.|
|S/N||Antimicrobial Agent||Symbol||Disc Content (μg)||Susceptibility (n = 20)|
|Resistant No. (%)||Intermediate No. (%)||Sensitive No. (%)|
|1||Ampicillin||Amp||25||13 (65.0)||5 (25.0)||2 (10.0)|
|2||Cefuroxime||Cef||20||10 (50.0)||3 (15.0)||7 (35.0)|
|3||Chloramphenicol||Chl||10||1 (5.0)||2 (10.0)||17 (85.0)|
|4||Ciprofloxacin||Cip||5||2 (10.0)||0 (0.0)||18 (90.0)|
|5||Cotrimoxazole||Cot||50||3 (15.0)||1 (5.0)||16 (80.0)|
|6||Gentamicin||Gen||10||2 (10.0)||2 (10.0)||16 (80.0)|
|7||Nalidixic Acid||Nal||30||11 (55.0)||2 (10.0)||7 (35.0)|
|8||Nitrofurantoin||Nit||100||9 (45.0)||3 (15.0)||8 (40.0)|
|9||Norfloxacin||Nor||10||0 (0.0)||3 (15.0)||17 (85.0)|
|10||Tetracycline||Tet||50||15 (75.0)||2 (10.0)||3 (15.0)|
|Table 5. Plasmid Profile and Multidrug Resistance Patterns of Plasmid-Containing E. coli Isolates.|
|E. coli isolates||Number of plasmids||Antibiotics to which Isolates were Resistant|
|JC15*||1||3||Amp, Tet, Cot|
|LR11*||2||4||Amp, Tet, Nit, Nal|
|JC11||1||4||Amp, Tet, Nit, Nal|
|BS12*||1||4||Amp, Tet, Nit, Cef|
|JC28||1||4||Amp, Tet, Cip, Cot|
|AS04*||1||5||Amp, Tet, Nit, Nal, Cef,|
|FD08*||2||5||Amp, Tet, Nit, Nal, Cef|
|AS06||1||5||Amp, Tet, Nit, Nal, Cef|
|SB06||2||5||Amp, Tet, Nit, Nal, Cip|
|SB13||1||5||Amp, Tet, Nit, Nal, Cip|
|KR10||1||5||Amp, Tet, Nit, Nal, Cot|
|HR09||1||5||Cef, Tet, Nit, Nal, Cot|
|SB04||2||6||Amp, Tet, Nit, Nal, Cip, Cot|
|IR10||1||6||Amp, Tet, Nit, Nal, Cef, Cot|
|JC13||1||6||Amp, Tet, Cef, Cip, Cot, Chl|
|FD07*||2||7||Amp, Tet, Nit, Nal, Cef, Cip, Cot|
|SB09||2||7||Amp, Tet, Nit, Nal, Cef, Cip, Cot|
|JR10||3||7||Amp, Tet, Nit, Nal, Cef, Cip, Cot|
|BS06||1||7||Amp, Tet, Nit, Nal, Cef, Cot, Chl|
|KR08||2||8||Amp, Tet, Nit, Nal, Cef, Cip, Cot, Chl|
|AS03||1||9||Amp, Tet, Nit, Nal, Cip, Cot, Chl, Gen, Nor|
Legend:*E. coli O157 strains;**Amp, ampicllin; Cef, cefuroxime; Cot, cotrimoxazole; Tet, tetracycline; Chl, chloramphenicol; Nit, nitrofurantoin; Nal, nalidixic acid; Cip, ciprofloxacin; Gen, gentamicin; Nor, norfloxacin.
© 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).